Abstract:In complex genetic disorders such as schizophrenia, endophenotypes have potential utility both in identifying risk genes and in illuminating pathophysiology. This is due to their presumed status as closer in the etiopathological pathway to the causative genes than is the currently defining clinical phenomenology of the illness and thus their simpler genetic architecture than that of the full syndrome. There, many genes conferring slight individual risk are additive or epistatic (interactive) with regard to cumulative schizophrenia risk. In addition the use of endophenotypes has encouraged a conceptual shift away from the exclusive study of categorical diagnoses in manifestly ill patients, towards the study of quantitative traits in patients, unaffected relatives and healthy controls. A more recently employed strategy is thus to study unaffected first-degree relatives of schizophrenia patients, who share some of the genetic diathesis without illness-related confounds that may themselves impact fMRI task performance. Consistent with the multiple biological abnormalities associated with the disorder, many candidate endophenotypes have been advanced for schizophrenia, including measures derived from structural brain imaging, EEG, sensorimotor integration, eye movements and cognitive performance (Allen et al., 2009), but recent data derived from quantitative functional brain imaging measures present additional attractive putative endophenotypes. We will review two major, conceptually different approaches that use fMRI in this context. One, the dominant paradigm, employs defined cognitive tasks on which schizophrenia patients perform poorly as "cognitive stress tests". The second uses very simple probes or "task-free" approaches where performance in patients and controls is equal. We explore the potential advantages and disadvantages of each method, the associated data analytic approaches and recent studies exploring their interface with the genetic risk architecture of schizophrenia.

Advances in endophenotyping schizophrenia

Convergent approaches for defining functional imaging endophenotypes in schizophrenia

Brain structure abnormality as genetic endophenotype of schizophrenia

The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project.

Genes and Structural Brain Imaging in Schizophrenia

Advances in Molecular Genetics of Schizophrenia

Finding Suitable Phenotypes for Genetic Studies of Schizophrenia: Heritability and Segregation Analysis

Genome-wide approaches to schizophrenia

A genome-wide association study of attention and executive function in patients with schizophrenia

Genetic Overlap among Intelligence and Other Candidate Endophenotypes for Schizophrenia

Prenatal Exposure to Famine and Brain Morphology in Schizophrenia

Progress in the Studies on the Molecular Genetics of Schizophrenia

An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation

Psychosis Endophenotypes: A Gene-Set-Specific Polygenic Risk Score Analysis.

Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.

Associations Between Brain Abnormalities and Common Genetic Variants for Schizophrenia: a Narrative Review of Structural and Functional Neuroimaging Findings

Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives

Biological insights from 108 schizophrenia-associated genetic loci

Multifaceted genomic risk for brain function in schizophrenia.

A Polygenic Risk Score Analysis of Psychosis Endophenotypes Across Brain Functional, Structural, and Cognitive Domains.

Genes for schizophrenia? Recent findings and their pathophysiological implications